RA
DXCM icon

Resolute Advisors’s DexCom DXCM Stock Holding History

Resolute Advisors’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-120
Closed -$16K – 287
2021
Q3 		$16K Hold
120
– – ﹤0.01% 253
2021
Q2 		$13K Buy
+120
New +$11.5K ﹤0.01% 238
2021
Q1 		– Sell
-12
Closed -$1K – 437
2020
Q4 		$1K Buy
+12
New +$1.07K ﹤0.01% 103

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Resolute Advisors's DXCM Position: Q4 2021 in Review

Resolute Advisors sold out of DexCom (DXCM) in Q4 2021, closing a stake of 120 shares — an estimated $16K sold.

Resolute Advisors first reported a position in DXCM in Q4 2020 and held it in 3 quarters. The position peaked at $16K in Q3 2021. 930 funds tracked by Wall St. Rank hold DXCM as of Q4 2021.

  • Resolute Advisors reported no remaining DexCom position as of Q4 2021 after selling out during the quarter.
  • Resolute Advisors sold 120 DexCom shares in Q4 2021, an estimated $16K.
  • Resolute Advisors first reported a position in DexCom in Q4 2020 and held it in 3 quarters.
  • Resolute Advisors's DexCom position peaked at $16K in Q3 2021.
  • 930 funds tracked by Wall St. Rank held DexCom as of Q4 2021.

Based on Resolute Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.